Please use this identifier to cite or link to this item:
https://www.arca.fiocruz.br/handle/icict/8094
HBV/HDV CO-INFECTION IN THE WESTERN BRAZILIAN AMAZONIA: AN INTRIGUING MUTATION AMONG HDV GENOTYPE 3 CARRIERS
Author
Affilliation
Inserm. Lyon, France
Inserm. Lyon, France
Fundação Oswaldo Cruz. Centro de Pesquisa Gonçalo Moniz. Laboratório de Patologia e Biologia Molecular. Salvador, BA, Brasil
Acre State Secretariat of Health. Rio Branco, Brasil
Acre State Secretariat of Health. Rio Branco, Brasil
Institute of Tropical Medicine of Amazonas. Manaus, AM, Brasil
International Agency for Research on Cancer. IARC. World Health Organization. WHO. Lyon, France
Inserm. Lyon, France
Fundação Oswaldo Cruz. Centro de Pesquisa Gonçalo Moniz. Laboratório de Patologia e Biologia Molecular. Salvador, BA, Brasil
Inserm. Lyon, France / Service d’H epato-Gastroent erology. H^opital de la Croix-Rousse. Lyon, France
Inserm. Lyon, France / Service d’H epato-Gastroent erology. H^opital de la Croix-Rousse. Lyon, France
University Hospital. Federal University of Bahia. Amazon Hepatitis Group. Salvador, BA, Brasil
Federal University of Rondônia. Rondônia, Porto Velho, Brasil / Fundação Oswaldo Cruz. Rondônia, Porto Velho, Brasil
University Hospital. Federal University of Bahia. Amazon Hepatitis Group. Salvador, BA, Brasil
Fundação Oswaldo Cruz. Centro de Pesquisa Gonçalo Moniz. Laboratório de Patologia e Biologia Molecular. Salvador, BA, Brasil / University Hospital. Federal University of Bahia. Amazon Hepatitis Group. Salvador, BA, Brasil
Inserm. Lyon, France
Fundação Oswaldo Cruz. Centro de Pesquisa Gonçalo Moniz. Laboratório de Patologia e Biologia Molecular. Salvador, BA, Brasil
Acre State Secretariat of Health. Rio Branco, Brasil
Acre State Secretariat of Health. Rio Branco, Brasil
Institute of Tropical Medicine of Amazonas. Manaus, AM, Brasil
International Agency for Research on Cancer. IARC. World Health Organization. WHO. Lyon, France
Inserm. Lyon, France
Fundação Oswaldo Cruz. Centro de Pesquisa Gonçalo Moniz. Laboratório de Patologia e Biologia Molecular. Salvador, BA, Brasil
Inserm. Lyon, France / Service d’H epato-Gastroent erology. H^opital de la Croix-Rousse. Lyon, France
Inserm. Lyon, France / Service d’H epato-Gastroent erology. H^opital de la Croix-Rousse. Lyon, France
University Hospital. Federal University of Bahia. Amazon Hepatitis Group. Salvador, BA, Brasil
Federal University of Rondônia. Rondônia, Porto Velho, Brasil / Fundação Oswaldo Cruz. Rondônia, Porto Velho, Brasil
University Hospital. Federal University of Bahia. Amazon Hepatitis Group. Salvador, BA, Brasil
Fundação Oswaldo Cruz. Centro de Pesquisa Gonçalo Moniz. Laboratório de Patologia e Biologia Molecular. Salvador, BA, Brasil / University Hospital. Federal University of Bahia. Amazon Hepatitis Group. Salvador, BA, Brasil
Abstract
SUMMARY. HDV infection still remains a serious public
health problem in Amazonia. There are few data regarding
the biomolecular aspects of HBV/HDV co-infection in this
region. We studied 92 patients HBsAg+/anti-HDV IgG+ followed
at the Hepatitis Referral Centers of Porto Velho
(RO), Rio Branco and Cruzeiro do Sul (AC), Brazil, from
March 2006 to March 2007 for whom the HDV and/or
the HBV genotype could be determined. The HDV genotype
could be determined in 90 patients, while the HBV genotypes
could be positively determined in 74. HBV subgenotype
F2 is the most prevalent (40.2%), followed by the
subgenotypes A1 (15.2%) and D3 (8.7%), while 16.4%
were other subgenotypes or genotypes, 4.3% were
discordant and 15.2% were unamplifiable. Surprisingly,
HDV genotype 3 (HDV-3) was found in all of the HBV/
HDV-infected patients that could be genotyped for HDV,
confirming that HDV-3 can associate with non-F HBV
genotypes. However, a HDV-3 mutant was found in 29.3%
of patients and was more frequently associated with non-F
HBV genotypes (P < 0.001) than were nonmutant strains,
suggesting that the mutation may facilitate association of
HDV-3 with non-F HBV genotypes.
Share